At Neurosketch, we are committed to advancing neurological healthcare by developing AI-driven tools for early diagnosis, with a special focus on neurodegenerative diseases like Parkinson’s. We are proud to collaborate with leading neurologists and senior doctors who provide expert guidance in shaping our diagnostic solutions. Our platform is backed by cutting-edge research and development, ensuring that every solution is scientifically sound and practical for real-world application.
By focusing on early detection, we aim to improve patient outcomes and accessibility. We are actively working on expanding our platform to diagnose other neurological conditions, continuously refining our AI models to provide more accurate results.
Market Opportunity:
The global demand for early detection of neurodegenerative diseases is rapidly increasing. With an ageing population and rising healthcare costs, scalable and effective diagnostic tools are critical. Neurosketch stands out by combining advanced AI technology with the medical expertise of senior neurologists, giving us a unique position in this multi-billion-dollar market.
Financials:
We are seeking investment to further our research and development efforts, expand our database, and accelerate the training of our AI models. This funding will also support regulatory approvals, global partnerships, and ongoing collaborations with healthcare institutions. Our projected growth includes revenue from subscription models, licensing of our AI tools, and partnerships with insurance and telemedicine providers. With a strong focus on R&D, we aim to lead the market in innovation and quality.
Join us in advancing the future of neurological healthcare. For more information, visit https://pdneurosketch.netlify.app/ and have a look at our business plan NeuroSketch -Business Model Canvas.
Get Ready: Beta Version for User Testing Coming Soon
Reviews
There are no reviews yet.